Norfoalk
Investor profile | Builders Republic
About
Norfoalk is the private investment holding (Family Office) of entrepreneur Jean-Guillaume Lafay. Following the successful exit of his biotech company, Mablink Bioscience, to Eli Lilly in 2023, Lafay established Norfoalk to manage his personal investments, focusing primarily on innovation in the healthcare and deeptech sectors.
Key facts
- Type
- Family Office
- Stages
- Pre-Seed,Seed
- Sectors
- Biotech,Healthcare
- Headquarters
- France
- Offices
- Lyon
- Geographic focus
- France
- Lead / Follow
- Follower
- Founded
- 2020
Notable investments in France
Axoltis Pharma
Key differentiators
Sector Specialist